Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region by Dunnick, Wesley A. et al.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 206 No. 12  2613-2623
www.jem.org/cgi/doi/10.1084/jem.20091280
2613
           Class switch recombination (CSR) and somatic 
hypermutation (SHM) occur during antigen-
driven diff   erentiation of B lymphocytes. The 
heavy chain class switch is a DNA recombina-
tion event that occurs between a switch (S) re-
gion upstream of the Cμ gene and a second 
S region upstream of one of the     ,     , or      heavy 
chain genes ( Stavnezer, 2000 ;  Manis et al., 2003 ). 
As a result of this deletional recombination 
event, the assembled VDJ exon is moved into 
physical and functional association with a new 
heavy chain gene, resulting in new eff  ector func-
tions of the expressed immunoglobulin. SHM 
introduces point mutations in the VDJ exon and 
several hundred basepairs downstream of the 
VDJ exon; however, the C region is spared ( Storb 
and Stavnezer, 2002  ). The rate of SHM can 
be as high as 0.1% per nucleotide per cell divi-
sion. Both CSR and SHM are dependent on the 
action of the B cell–specifi  c activation-induced 
cytidine deaminase (AID;   Muramatsu et al., 2000  ; 
  Revy et al., 2000  ). 
  Both CSR and SHM are inactive in resting 
B cells, but are strongly induced during antigen-
driven diff  erentiation. The regulatory elements 
that control this dramatic up-regulation are poorly 
defi  ned. Switch recombination is reduced, to a 
small extent, by deletion of the intronic μ en-
hancer (  Bottaro et al., 1998  ;   Sakai et al., 1999  ). It 
is clear that other elements must also play a role in 
the regulation of both CSR and SHM. The heavy 
chain 3     enhancer region is a strong candidate for 
this regulation (  Cogne and Birshtein, 2004  ). The 
region comprises a cluster of at least four DNase I 
hypersensitive sites (called HS3A; HS1,2; HS3B; 
and HS4), which are dispersed over a 28-kb 
region, beginning 4-kb downstream of the C     
gene. The heavy chain 3     enhancers enhance 
transcription with a high level of B cell specifi  city 
and with substantial synergy among the four HS 
sites (  Cogne and Birshtein, 2004  ). Consistent 
with a role in CSR, the enhancers can up-regulate 
the expression of “germline” transcripts from 
transgenic heavy chain genes (  Collins and 
Dunnick, 1999  ;   Laurencikiene et al., 2007  ). 
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  Both class switch recombination (CSR) and somatic hypermutation (SHM) require tran-
scription and the trans-acting factor activation-induced cytidine deaminase (AID), and 
must be up-regulated during antigen-dependent differentiation of B lymphocytes. To test 
the role of the heavy chain 3     enhancers in both CSR and SHM, we used a BAC transgene 
of the entire heavy chain constant region locus. Using Cre-loxP recombination to delete a 
28-kb region that contains the four known 3     heavy chain enhancers, we isolated lines of 
BAC transgenic mice with an intact heavy chain locus and paired lines in the same chromo-
somal insertion site lacking the 3     enhancers. Intact heavy chain transgenes undergo CSR 
to all heavy chain genes and mutate their transgenic VDJ exon. In paired transgenes lacking 
the 3     enhancer region, CSR to most heavy chain genes is reduced to     1% of the levels for 
intact heavy chain loci; SHM is also reduced. Finally, we fi  nd that in B cells with a trans-
gene lacking the 3     enhancers, interchromosomal recombination between the transgenic 
VDJ exon and the endogenous heavy chain C genes is more easily detected than CSR within 
the transgene. 
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quence at the C terminus of secreted version of C    2a allows 
the detection of transgene-specifi  c IgG2a. Fourth, loxP sites 
were inserted 5     of HS3A and 3     of HS4. Fifth, two copies of 
the chicken     -globin insulator were inserted 3-kb 5     of the 
anti-ARS VDJ exon. In the same targeting construct, a Not1 
site was engineered into the BAC just 5     to the insulators. 
Five lines of transgenic mice with the ARS/Igh11 construct 
were derived. In addition, a single mouse from line 761 sur-
vived with both the ARS/Igh11 transgene and the Ella Cre 
transgene. We could analyze her off  spring as 761     mice, but 
could not obtain off  spring with an intact ARS/Igh11 trans-
gene. Hence, we had only this single mouse as a control. The 
transgene excludes endogenous heavy chain expression in all 
six types of mice because almost all B cells express transgenic 
IgM  a   only, and very few B cells express endogenous IgM  b   only 
(  Fig. 1 B  ). This is in contrast to the versions of the ARS/Igh 
transgene we studied in the past, where allelic exclusion of 
the endogenous genes was incomplete in the majority of lines 
with a full-length heavy chain transgene (  Gao et al., 2005  ). 
The improved allelic exclusion may be caused by the action 
of the chicken     -globin insulator. Alternatively, because we 
prepare the transgene by injection of the large Not1 fragment 
containing the bulk of the heavy chain locus, we eliminate a 
6-kb Not1 fragment (from the 5     end of ARS/Igh11 to the 
NotI site added with the chicken     -globin insulator;   Fig. 1 A  ). 
In published versions of the heavy chain transgene, a D ele-
ment in this 6-kb NotI fragment may undergo D to JH3 or 
JH4 joining within the transgene, deleting the transgenic VDJ 
exon and thus excluding transgenic expression (  Dunnick et al., 
2005  ;   Gao et al., 2005  ). 
  We also prepared paired versions of the ARS/Igh11 
transgenic lines by Cre-loxP deletion of the 28-kb fragment, 
including the four known 3     enhancers (the “    ” transgenic 
lines). In lines 231    , 234    , and 761     (not depicted), trans-
genic μ expression is similar to that of the paired, intact line. 
However, in lines 820    , 774    , and 336     (  Fig. 1 D  ), both 
surface IgM and VDJCμ mRNA expression is reduced two- 
to fi  vefold compared with the intact lines (  Fig. 1, B and D  ). 
However, neither B cell development nor allelic exclusion 
(  Fig. 1 B   and   Fig. S1  ) is altered by deletion of the 3     enhancers. 
Depending on the transgenic line, the deletion of the 3     en-
hancers has a small or no eff  ect on transgenic μ expression. 
We also determined copy number for 12 DNA segments across 
the ARS/Igh11 transgene, and found that paired intact and   
   versions of the transgene had identical (820, 774, 761, and 
336) or similar copy numbers (  Fig. S2  ). Lines 231     and 234     
appeared to have one less transgene copy than their intact 
paired lines. 
  Specifi  c deletion of the 28-kb 3     enhancer region 
drastically reduces CSR compared with the levels of 
recombination in B cells with an intact ARS/Igh transgene 
  B cells from each transgenic line with an intact heavy chain 
transgene-secreted transgenic IgG1, IgG2a, and IgA after 
culture with the appropriate inducing agents (  Fig. 2  ).   The 
amount of antibody secreted varied, in part because of the 
Germline transcripts for each heavy chain gene are initiated 
in an exon (termed “I”) upstream of the S region and con-
tinue through the S region and C region. Germline tran-
scripts represent the first phase of CSR, the opening of 
the chromatin for a specific heavy chain gene (  Stavnezer-
Nordgren and Sirlin, 1986  ;   Yancopoulos et al., 1986  ). HS3B 
and HS4 are known to play a role in CSR, as their deletion 
from the germline aff  ects CSR to some genes profoundly 
(    3 and     2b), aff  ects other genes by a reduction to     10% of 
wild-type values (    2a,     , and     ), but aff  ects CSR to     1 and 
transcription of the Cμ gene by a minor increment (  Pinaud et al., 
2001  ). Unfortunately, it has not been possible to delete all four 
of the HS sites from the germline via ES cell technology, and 
so understanding of the regulation of CSR remains incomplete. 
  To study CSR, we use a 230-kb BAC that includes an 
inserted VDJ exon (encoding anti-arsonate [ARS] binding), 
all of the murine heavy chain S and C regions, and the known 
3     enhancers. The transgenic     ,     , and      heavy chain genes 
undergo germline transcription and CSR with the same reg-
ulation as the endogenous genes. We had previously identi-
fi  ed two truncated versions of this transgene that lacked the 
3     enhancers as well as the C     gene, and showed that these 
truncated heavy chain transgenes could not undergo CSR to 
any of the      genes, including     1 (  Dunnick et al., 2005  ). Both 
truncated heavy chain transgenes had deleted C    , and one 
had deleted C    ; therefore, we could not test the eff  ect of the 
deletion of the 3     end of the locus on expression of these two 
isotypes. Furthermore, because of the spurious nature of the 
deletions, whether the defi  ned HS sites or the deletion of ad-
ditional elements within the 63-kb deletion were responsible 
for the phenotype, remained unclear. 
  Here, we have generated new transgenic constructs where 
the 28-kb region that comprises the 4 known HS sites corre-
sponding to the 3     heavy chain enhancers is fl  anked by loxP 
sites. After Cre-mediated deletion, we could compare intact 
transgenes to transgenes lacking the 3     enhancer region, with 
the paired transgenes in the same chromosomal insertion site 
and with identical or similar copy number. The functional 
analysis of these transgenes has allowed us to evaluate the de-
letion of all four HS sites from the heavy chain locus on CSR 
to all isotypes. It has also allowed us to test the role of these 
elements in SHM of the transgenic V region. Given the in-
ability to generate deletions at the genomic locus, this is the 
best available method for studying cis-acting elements that 
regulate heavy chain diversifi  cation. 
  RESULTS 
  B cell development in ARS/Igh transgenic mice lacking 
the heavy chain 3     enhancers 
  The ARS/Igh11 transgene has fi  ve salient features (  Fig. 1 A  ).   
First, it is derived from strain 129 DNA (Igh  a  ) and therefore 
diff  ers from the endogenous C57BL/6 genes (Igh  b  ) by many 
polymorphisms. Second, 4-bp insertions in I    1 and I    2a al-
low one to distinguish germline transcripts from the trans-
gene from those from the endogenous genes (  Dunnick et al., 
2004  ,   2005  ). Third, the insertion of a Flag tag-encoding se-JEM VOL. 206, November 23, 2009 
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sometimes expressed transgenic IgA amounts that were 
slightly in excess of the amounts secreted by control, non-
transgenic B cells (  Fig. 2 C  ). Supernatant fl  uids from B cells 
from both      mice and nontransgenic mice were shown to 
express signifi  cant amounts of endogenous Ig (  Fig. S3  ) and 
supernatants from      mice expressed transgenic IgM (not 
depicted), demonstrating that these B cells underwent acti-
vation and diff  erentiation. 
exact inducing agent used, but mostly because of unavoid-
able variation in the B cell cultures. However, B cells from 
mice with deletion of the 3     enhancers from the transgene 
(820    , 774    , etc.) rarely secreted amounts of transgenic 
IgG2a and IgG1 above that of control nontransgenic B cells 
(  Fig. 2, A and B  ). The one exception to this was IgA; spe-
cifi  cally, for two of the transgenic lines, 336     and 234     
(each with two copies of the transgene), transgenic B cells 
    Figure 1.     Structure of the ARS/Igh11 transgene and transgenic μ expression.   (A) Heavy chain variable region and constant region coding seg-
ments are shown as gray rectangles. Both the intronic enhancer (between the VDJ and C     exons) and the 3     enhancers are shown as black circles. “2X 
INS” indicates two copies of the chicken     -globin insulator. Expression of Cre from the EIIa Cre transgene results in deletion of the 28-kb region contain-
ing the four 3     enhancers (A, bottom), but spares 15 kb of sequence that fl  ank the 3     end of the enhancer region. 761* was not established as paired 
transgenic lines. We had only a mother with intact genes and 761     offspring from her, and so could test these mice in only a single experiment. (B) Analy-
sis of surface Ig expression by fl  ow cytometry. Line 336 B cells were tested with a different concentration of anti-B220, resulting in a lower apparent 
surface expression. Expression in lines 234, 234    , 231, 231    , 761, and 761     was similar to surface Ig expression in line 336. (C) The relative surface 
transgenic IgM  a   expression in lines 820 and 820    , and 774 and 774    , is shown as histograms. (D) Transgenic VDJCμ expression, as determined by 
RT-PCR, using fi  vefold dilutions of cDNA. Each experiment shown was repeated in one or two additional experiments.     2616 Enhancers for class switch and hypermutation   | Dunnick et al. 
intact ARS/Igh11 transgene (  Fig. 3  ).   In contrast to VDJ 
recombination during B cell development, CSR-associated 
germline transcription is biallelic (  Delpy et al., 2003  ). There-
fore, transgenic cells also expressed endogenous transcripts. 
Transgenic germline transcripts were distinguished from en-
dogenous germline transcripts by migration polymorphisms 
(    2a gene;   Fig. 3 A  ) or by restriction site polymorphisms (see 
below). Using endogenous germline transcripts for normal-
ization, B cells from enhancer-deleted mice express 10–20% 
of the amount of germline transcripts of B cells with intact 
transgenes. The residual germline transcription after deletion 
of the 3     enhancers, particularly for the     1 (  Fig. 4 A  ) and      
(  Fig. 5 A  ) genes, probably results from the ability of these 
heavy chain genes (for example, as isolated transgenes) to express 
some germline transcripts (  Xu and Stavnezer, 1992  ;   Elenich 
et al., 1996  ;   Collins and Dunnick, 1999  ;   Laurencikiene et al., 
2007  ).      However, for     ,     , and the 4      heavy chain genes, the 
28-kb 3     enhancer region is necessary for the expression of 
physiological levels of germline transcripts. 
  Transgenic post-switch transcripts were distinguished 
from potential endogenous transcripts using a transgene-
specifi  c RT-PCR (  Dunnick et al., 2005  ); note that nontrans-
genic C57BL/6 B cells produce only a remnant of a signal 
(  Fig. 3 B  ). All lines with an intact ARS/Igh11 transgene ex-
pressed VDJC    2a transcripts (  Fig. 3 B  ). In contrast, transgenes 
lacking the 3     enhancer region expressed barely detectable 
amounts of post-switch VDJC    2a transcripts (lines 820    , 
336    , and 234    ;   Fig. 3 B  ). As an exception, line 774     ex-
pressed post switch VDJC    2a (and other VDJCH transcripts, 
see below). As we discuss in the section after next, line 774 
inserted near the endogenous heavy chain locus, and the post-
switch transcripts are the joining of transgenic VDJ to endog-
enous CH genes. All cultures produced IμC    2a transcripts (  Li 
et al., 1994  ), demonstrating that the nontransgenic and      cul-
tures contained viable B cells, were activated in vitro, switched 
their endogenous     2a genes, etc. This enhancer-dependent 
defect was not restricted to the     2a genes: analogous results 
were obtained for the     3,     2b, and      heavy chain genes 
(  Fig. S4  ) as well as the transgenic     1 (  Fig. 4  ) and      (  Fig. 5  ) 
genes. Therefore, the 28-kb 3     enhancer region may be impor-
tant for switch recombination in DNA. Alternatively, it is pos-
sible that deletion of the 3     enhancers has no eff  ect on DNA 
recombination, and the reduced amount of post-switch tran-
scripts is the result of a lack of enhancement of those transcripts 
from a correctly switched locus (  Shi and Eckhardt, 2001  ). 
  The 28-kb 3     enhancer region is essential 
for DNA recombination during CSR 
  To assess the possibility that the lack of expression of trans-
genic post-switch transcripts from a heavy chain transgene 
with the deletion of the 28-kb 3     enhancer region might 
be caused by a failure to undergo switch recombination in 
DNA, we tested for CSR in DNA by a modifi  ed direct cir-
cularization PCR (DC-PCR) technique (  Chu et al., 1992  ). 
We digested the DC-PCR products with DdeI, which 
distinguishes the transgenic and endogenous     2a genes 
    Figure 2.     Transgenic IgG expression in vitro.   Supernatants of cul-
tured B cells (with cytokines as indicated in each panel) from various 
transgenic and nontransgenic mice were tested. (A) Transgenic Flag+ 
IgG2a expression; (B) transgenic IgG1  a   expression; and (C) transgenic 
AD8+ (idiotype+) IgA expression. Each data point represents an indepen-
dent culture, derived from independent transgenic mice. In this and sub-
sequent fi  gures, the 774 line and 820 line were tested in separate 
experiments from the 336 line, the 234 line, the 231 line, and the 
761 mice, as the latter four mice were established 1 yr later.     
  The 28-kb 3     enhancer region is necessary 
for the production of CSR-associated transcripts 
  Before CSR, germline transcripts are initiated from each 
switch region (I) promoter and are thought to prepare the 
locus for recombination. After CSR, post-switch transcripts 
are expressed and translated into the switched heavy chain. 
Both germline transcripts and post-switch VDJC    2a tran-
scripts were expressed from the transgene in B cells with an JEM VOL. 206, November 23, 2009 
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(  Fig. 3 D  ). Transgenic DC-PCR fragments were easily de-
tected in DNA samples from B cells with intact transgenes. 
In addition, the amount of transgenic fragment (from one 
to three genes) was comparable to the amount of the en-
dogenous fragment (from two genes). This indicates that 
CSR of the ARS/Igh transgene is more or less as effi   cient as 
CSR of the endogenous genes. However, specifi  c removal 
of the 3     enhancers from the integrated BAC transgene 
by Cre-recombination, clearly abrogated CSR in all B cell 
samples (including line 774    ). Analogous results were ob-
tained for CSR at the DNA level for the     1 gene (  Fig. 4 D  ). 
These results demonstrate that the 3     enhancer region dele-
tion has a profound eff  ect on CSR at the level of DNA 
recombination. 
  Lack of CSR in enhancer-deleted heavy chain transgenes 
can be partially rescued by recombination in trans 
with the endogenous locus 
  Enhancer deletion had abrogated the production of post-
switch transcripts in all but one of our transgenic strains: in 
line 774, deletion of the 3     enhancer region had a modest 
eff  ect on the levels of post-switch transcripts (  Figs. 3–5   and 
Fig. S4). We therefore wondered if the transgenic BAC in 
that line had inserted in a privileged location. Indeed, we no-
ticed that, in a standard genetic cross, the 774 transgene 
cosegregated with the endogenous heavy chain locus in each 
of 13 off  spring. Therefore, the ARS/Igh transgene in line 774 
is inserted into murine chromosome 12, in linkage with the 
heavy chain locus. It does not replace the endogenous locus, 
as endogenous genes are retained in mice with an intact 774 
transgene on one chromosome and a 774     transgene on the 
other homologue (unpublished data). 
  We therefore considered the possibility that the VDJC     
transcripts observed in line 774     B cells were actually derived by 
a recombination event between the VDJ exon of the transgene 
and the C     exons of the endogenous locus. To test this, we am-
plifi  ed VDJC     transcripts from various transgenic B cells, and 
then distinguished those with an endogenous C     from those 
with a transgenic C     by digestion with SstI (  Fig. 5 D  ). At least 
15% of the transgenic VDJ-containing transcripts from line 774 
B cells are associated with endogenous C     sequences, and almost 
all of the transcripts from line 774     B cells are associated with 
endogenous C     sequences. Therefore, the 774 line is not an 
outlier with regard to production of post-switch transcripts: the 
enhancer-deleted version switches just as poorly within the 
transgene as any of the other deleted lines. The milder eff  ect 
    Figure 3.     Transgenic expression of the     2a heavy chain gene.  
(A) T cell—depleted splenocytes from various transgenic mice were cul-
tured in activators and IFN-     as indicated at the top of the fi  gure. Germ-
line transcripts from the endogenous and transgenes were distinguished 
by a migration polymorphism, which is due in part to a 4-bp insertion in 
transgenic I    2a. The 820 CD40L + IFN-     sample was run on the same gel 
as the other seven samples on the left. However, because of the increased 
expression of all germline transcripts in this sample, the radioactivity was 
very high. Therefore, a different exposure of this lane is shown. (B) Post-
switch transcripts. In this Figure, and in   Fig. 4  ,   Fig. 5  , and Fig. S4, intact 
and      cDNA samples were fi  rst equalized for the expression of I   CH  tran-
scripts, and then the same concentrations of cDNA were tested for VDJCH 
expression. The expression patterns of germline and post-switch tran-
scripts expressed by B cells from lines 231     and 231 were identical to 
those of lines 336, 336    , 234, and 234     (not depicted). (C) HPRT mRNA 
expression. Two concentrations of cDNA were tested by RT-PCR, repre-
senting one-fi  fth and one-twenty-fi  fth of the amount of cDNA from the 
indicated cultures tested for post-switch transcripts in B. (D) μ-   2a  CSR 
of the endogenous and transgenes was tested by DC-PCR. In the sche-
matic, the gray portion depicts sequences 5     of Sμ and the black portion 
depicts sequences 3     of  S  2a.   Dde  1 sites (arrows in schematic) differenti-
ate DC-PCR products from the endogenous genes and transgene. A 4-bp 
insertion in the transgene (black triangle) also differentiates one trans-
genic fragment from its endogenous counterpart. Each experiment shown 
was repeated in one or two additional experiments. Black lines between 
lanes indicate that the order of the lanes has been rearranged from the 
original electronic fi  le, or that the lanes are derived from an independent 
experiment.   
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IgG1 because detection requires a transgenic CH region (  Fig. 2, 
A and B  ). Also consistent with this explanation, CSR within the 
774     transgene at the DNA level cannot be detected (  Fig. 3 D  ). 
  Products of trans-recombination are positively selected 
in vivo, during an immune response 
  To determine whether trans-recombination was functional 
in vivo, we amplifi  ed and sequenced the transgenic VDJ from 
RNA of B cells from immunized spleen, 21 d after immuni-
zation (  Fig. S5  ) . As predicted from the in vitro data, transgenic 
apparent on post-switch transcripts in previous fi  gures is almost 
entirely caused by recombination with the endogenous CH 
genes. Consistent with this explanation, supernatant fl  uids from 
line 774     B cells do not secrete detectable transgenic IgG2a or 
    Figure 4.     Transgenic expression of the     1 heavy chain gene.   (A)  T 
cell–depleted splenocytes from the various transgenic mice were cultured 
in LPS or LPS+IL-4. Germline transcripts from the endogenous and trans-
genes were distinguished by a 4-bp insertion resulting in a TaqI restriction 
site (arrows in schematic). RNA samples were derived from cells cultured 
in LPS+IL-4. (B) Post-switch transcripts. Expression patterns for germline 
and post-switch transcripts from B cells from lines 234     and 234 were 
identical to those from lines 820     and 820 (not depicted). (C) HPRT 
mRNA expression. (D) μ-    1 CSR, distinguishing the transgene and endog-
enous genes, was tested by DC-PCR. Note that the 231     sample has a 
larger amount of fragment from the endogenous genes. (E) The same 
amount of 820     LPS+IL-4 and 820 LPS+IL-4 tested in Part B, and three 
fi  vefold dilutions of the 820 cDNA, were tested for transgenic VDJC   1 
expression. Each experiment shown was repeated in one or two additional 
experiments. Black lines between lanes indicate that the order of the lanes 
has been rearranged from the original electronic fi  le, or that the lanes are 
derived from an independent experiment.     
    Figure 5.     Transgenic expression of the      heavy chain gene.  
(A) Expression of      germline transcripts. Germline transcripts from the 
transgene were distinguished from transcripts from the endogenous genes 
by digestion of the 333-bp I   C    PCR products with PstI and SstI, as illus-
trated at the top of the fi  gure. The 263-bp endogenous fragment derives 
from an alternatively spliced version with a longer I     exon. (B) Post-switch 
transcripts. The expression patterns of germline and post-switch transcripts 
for lines 231     and 231 were similar to those of lines 234     and 234 (not 
depicted). Cells from C57BL/6, 820    , and 820 were treated with CD40L, 
with or without TGF     as indicated, instead of LPS. (C) HPRT transcripts. 
(D) Recombination between the transgenic VDJ and endogenous C     in  lines 
774 and 774    . Transgenic and endogenous C     sequences in mRNA, from 
B cells cultured in LPS+TGF    , were distinguished by a SstI site found in the 
endogenous, but not the transgenic, C    . Each experiment shown was re-
peated in one or two additional experiments.     JEM VOL. 206, November 23, 2009 
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VDJ recombination with the endogenous C     was frequent in 
line 774 (19 of 26 VDJ sequences had the endogenous C    ) 
and 774     (17 of the 18 VDJ sequences had the endogenous 
C    ). Furthermore, recombination of the transgenic 820 VDJ 
with the endogenous C     was infrequent (occurring only 4 
out of 34 sequences). Surprisingly however, recombination 
of the transgenic 820     VDJ with the endogenous C     was 
frequent in the enhancer-deleted line; 22 of 33 total se-
quences had the transgenic VDJ associated with an endoge-
nous C    . Apparently, during an immune response in vivo, 
there is a strong selection for the antibodies (on the cell sur-
face or secreted) that result from the virtually undetectable 
recombination between the transgene and the endogenous 
genes in lines 820 and 820     in vitro (  Fig. 5 D  ). 
  The 3     enhancers are important for somatic hypermutation 
  Past work has shown that elements within the 3     enhancer 
region (specifi  cally the HS3B and HS4 sites) were dispensable 
for SHM (  Le Morvan et al., 2003  ). To determine whether 
deletion of the entire 28-kb enhancer region had an eff  ect on 
mutation, we immunized our transgenic mice with ARS-KLH, 
and isolated GL7+/Fas+ (germinal center) B cells from their 
spleens 12 d after immunization. DNA from sorted B cells 
was used to amplify the VDJ exon and 3     fl  anking sequences, 
which were then cloned and sequenced. In contrast to most 
heavy chain transgenes which do not mutate at wild-type 
levels (  Giusti and Manser, 1993  ;   Unniraman and Schatz, 2007  ), 
our BAC transgenics were fully competent for SHM, accu-
mulating mutations at a rate of 0.3–0.8% (  Fig. 6  ).   Deletion of 
the enhancers had a major eff  ect on the frequency of muta-
tions. For example, the frequency of mutation in 820 VDJ 
and fl  anking region dropped from     0.46–0.06%, in the ab-
sence of the enhancers; this is close to the background rate of 
mutation caused by polymerase error during amplifi  cation 
(    0.02% or 2/10,000 nt). Similarly, the frequency of muta-
tion near the VDJ in the 336 line dropped from 0.36% to 
0.08%, and in the 774 line dropped from 0.72% to 0.23%. In 
each set of paired transgenic lines, the number of clones with 
multiple mutations was also reduced in the absence of the 
enhancers (  Fig. 6  ). 
  DISCUSSION 
  Several lines of work suggest that the 3     enhancer region 
would control CSR. Chromatin interactions between heavy 
chain genes and HS1,2 suggest functional interactions 
(  Wuerff  el et al., 2007  ). Deletions or replacements of individ-
ual hypersensitive regions (  Cogné et al., 1994  ;   Manis et al., 
    Figure 6.     Somatic hypermutation of transgenic VDJ exons and 
fl  anking sequences.   Part of the transgenic VDJ exon and 3     fl anking 
sequences (from germinal center B cells) were amplifi  ed, cloned, and se-
quenced. Mutations in the 3     171 bp of VDJH2 exon and 329 bp of 3    
fl  anking sequences are presented as pie charts, in which the sectors of the 
pie are proportional to the number of sequences with a given number of 
mutations. The number of sequences is shown in the center of the pie 
chart, and the number of mutations in some sectors is noted. For lines 
820, 820    , 774, and 774    , the data represent a compilation of sequences 
from two sorted cell samples derived from independent mice. For lines 
336 and 336    , the data are derived from one sorted cell sample each; a 
second set of sequences from the same cell sample yielded 0.21% muta-
tions in line 336 DNA and 0.02% mutations in line 336     DNA. For all 
three pairs of transgenic lines tested, the mutation frequency is greater in 
intact versus the enhancer-deleted line, P < 0.0001 (two-tailed   	  2   test, 
with Yate’s correction and one degree of freedom). Mutation frequencies 
in the intronic 329-bp were: line 820, 0.36% (27 mutations in 7557 nt); 
line 820    , 0.03% (4 mutations in 13,818 nt); line 774, 0.40% (43 muta-
tions in 10,857 nt); line 774    , 0.11% (14 mutations in 12,831 nt); line 
336, 0.16% (44 mutations in 27,636 nt); and 336    , 0.03% (9 mutations in 
30,268 nt). For each set of paired transgenic lines, the difference in in-
tronic mutations was signifi  cant at P < 0.0001 (two-tailed   	  2   test,  with 
Yate’s correction and one degree of freedom). In separate experiments, 
transgenic V region mutations were also determined in cloned mRNA 
(VDJC   1,  VDJC   2a, and VDJC    2b pooled sequences) from spleens of im-
munized line 820 mice (see text). The 820 VDJ exon had 1.67% mutations 
(128 mutations in 7680 nt sequenced from 30 clones). The 820 C     region 
had 0.1% mutations (10 mutations in 10,041 nt sequenced in the same 
30 clones). By a two-tailed   	  2   test, with Yate’s correction and one degree 
of freedom, the difference in mutation frequency in V and C is signifi  cant 
at P < 0.0001.     
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combination events predominate after induction of CSR. 
For example, recombination events between the VDJ of the 
774     transgene with the endogenous genes are easily de-
tected (  Fig. 5 D   and Results). If the 774/774     insertion site 
is within the VH cluster, and in the same orientation as the 
endogenous genes, recombination of the transgenic VDJ with 
endogenous CH must involve much greater distances than 
switch recombination within the transgene (because the VDJ 
exon must pass over all the transgenic CH to reach the en-
dogenous CH). If the 774/774     insertion site is in the op-
posite orientation to the endogenous genes, recombination 
of the transgenic VDJ with the endogenous CH genes must 
involve an inversion event. Finally, if the transgenic insertion 
is downstream of C     in either orientation, recombination of 
the transgenic VDJ and endogenous CH is more complex 
than CSR within the transgene. The VDJ and CH exons 
would be in the nonphysiological order, and may be inverted 
relative to one another. Selection during an immune response 
in vivo reveals the same recombination products in line 820    , 
where recombination between the transgenic VDJ and en-
dogenous CH genes (on diff  erent chromosomes!) is easier to 
detect than CSR within the 820     transgene. Similar recom-
bination events between the VDJ exon of heavy chain trans-
genes on one chromosome with endogenous heavy chain 
genes on another chromosome have been described in mul-
tiple reports (  Durdik et al., 1989  ;   Gerstein et al., 1990  ;   Giusti 
and Manser, 1993  ). The physical interactions that lead to 
these inter-chromosomal recombination events may be me-
diated by an interaction of the endogenous 3     enhancers with 
the transgenic intronic      enhancer, VH promoter, or Sμ re-
gion (  Wuerff  el et al., 2007  ). The inter-chromosomal events 
involving transgenes may also mimic CSR between allelic 
chromosomes (  Knight et al., 1995  ;   Reynaud et al., 2005  ). The 
3     enhancers seem to favor CSR between heavy chain genes 
within a single locus. An important experimental question for 
the future is whether the 3     enhancers have an additional func-
tion to suppress inter-chromosomal translocation events. 
  There has been considerable speculation about the poten-
tial role of the 3     enhancer region in SHM. Studies in trans-
genic mice where the various hypersensitive sites of the 3     
enhancers were ectopically placed on a regular transgene, have 
indicated a role for HS3B and HS4 (but not HS1,2) in the re-
cruitment of SHM to the transgene (  Terauchi et al., 2001  ). 
However, these data are complicated by the fact that regular 
transgenes are generally poor hypermutation targets, and also 
by the possibility that inclusion of HS3B and HS4 simply in-
creased the transcriptional effi   ciency of the transgene, as it is 
well known that the rates of mutation fl  uctuate with the rates 
of transcription. This possibility was not controlled for in these 
transgenic studies (  Terauchi et al., 2001  ). Other investigators, 
studying mice where the HS3B and HS4 elements were de-
leted from the germline, have reached the opposite conclusion, 
namely that joint deletion of these two elements does not 
aff  ect SHM of the endogenous IgH locus, thus suggesting that 
CSR and SHM can be uncoupled with regard to their depen-
dence on cis-regulatory elements (Le   Morvan et al., 2003  ). 
1998  ;   Seidl et al., 1999  ) implicate the 3     regulatory locus in 
CSR. Additionally, insertions of foreign sequence in the lo-
cus also aff  ect CSR, possibly by disrupting interactions be-
tween enhancer elements (  Seidl et al., 1999  ). However, any 
conclusions are complicated by the fact that clean deletion 
of single elements reveals only a minimal phenotype (  Manis 
et al., 1998  ;   Seidl et al., 1999  ;   Vincent-Fabert et al., 2009  ). 
Deletion of both HS3B and HS4 (  Pinaud et al., 2001  ) from 
the germline demonstrates a role in CSR to some heavy 
chain genes. To pursue the role of the 3     enhancer region, 
over the last 10 yr, several laboratories have attempted to de-
lete all four elements from the mouse germline, but for rea-
sons that remain unclear, this has not been achieved to date. 
  To study the role of the entire 3     enhancer region in anti-
body diversifi   cation processes, we have developed a BAC 
transgenic system from which we can delete all four 3     en-
hancer elements. For all our BAC ARS/Igh transgenes tested, 
CSR (and SHM) is similar, qualitatively and quantitatively, to 
that of the endogenous locus. CSR is quantitatively similar in 
diff  erent transgenic lines (  Figs. 2–5   and Fig. S4), indicating 
that insertion site eff  ects are relatively minor (line 774 being a 
special exception). At the same time, in all cases, enhancer 
deletion has a pronounced eff  ect on CSR, at the level of 
DNA recombination. Comparison of the amount of switch 
recombination in the “    ” lines to dose–response curves for 
both RT-PCR (  Fig. 4 E   and Fig. S4 D) and ELISA (Fig. S3) 
indicates that for most isotypes, CSR for the transgenes lack-
ing the 3     enhancers is less than 1% the level of CSR for intact 
transgenes. The only exception is the      heavy chain, where 
enhancer-deleted transgenic lines produce germline transcripts 
and post-switch transcripts above background levels (  Fig. 5 
A and B  , compare lanes 12, 14, and 18 to lane 11). For trans-
genic lines 336, 234, and 231 (two or more copies), transgenic 
IgA above background levels can be detected in the superna-
tants of cells with an enhancer-deleted transgene (  Fig. 2 C   and 
not depicted). These results suggest that transcription and re-
combination of the      heavy chain gene may depend on the 
3     enhancer region to a lesser extent than other heavy chain 
genes. Perhaps some ability to enhance CSR to the      heavy 
chain gene is encoded outside the 28-kb 3     enhancer region, 
and is most easily revealed when extra copies of the heavy 
chain transgene can insulate one of the      heavy chain genes. 
Alternatively, in a head-to-tail transgene confi  guration, the 
intronic μ enhancer of the downstream transgene might en-
hance CSR to the upstream      gene. Even though enhancer 
region deletion has a milder eff  ect on CSR to IgA, its absence 
signifi  cantly aff  ects both transcription and recombination to 
this isotype. In addition, CSR to the      gene is dramatically 
aff  ected by deletion of the 3     enhancer region in single copy 
mice (  Figs. 2 C   and   Fig. 5, B and D  ), and CSR to all other 
isotypes is practically nil, regardless of the transgene or copy 
number. Taken together, our experiments demonstrate that 
the 28-kb 3     enhancer region controls germline transcription 
and switch recombination to all heavy chain genes. 
  Remarkably, CSR within transgenes lacking the 3     en-
hancers is so ineffi   cient that intra- or interchromosomal re-JEM VOL. 206, November 23, 2009 
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into pSV1.RecA using SalI sites provided by intermediate cloning vectors. 
For insertion of a loxP site 5     of HS3A, 5     and 3     homology regions were 
identifi  ed from the sequence by   Garrett et al. (2005)  , and were amplifi  ed 
with an inserted loxP site (Table S1). The two homology regions were 
brought together using overlap extension (  Ho et al., 1989  ). The resulting 
targeting sequences were transferred to pSV1.RecA using HindIII sites li-
gated as linkers to the ends of the targeting fragments. For insertion of a loxP 
site 3     of HS4, the 5     and 3     homology regions were amplifi  ed with an in-
serted loxP site (Table S1). The two homology regions were brought to-
gether by digestion with HindIII and ligation, and the resulting targeting 
sequences were transferred to pSV1.RecA using the SalI sites at the ends. 
  Each of four targetings (previous two paragraphs) was completed in two 
stages. First, the targeting vector was cointegrated into the ARS/Igh BAC 
using 5     or 3     homology regions, expression of RecA, and selection for re-
sistance to tetracycline at high temperature (  Yang et al., 1997  ). Second, exci-
sion of the targeting vector was selected by resistance to fusaric acid (  Yang 
et al., 1997  ). Presence of the engineered insertion in the resulting BAC was 
verifi  ed by Southern hybridizations and PCR. In each case, the homology 
regions were cloned and sequenced to verify that no mutations had been in-
troduced during PCR amplifi  cation. The mutations to create SalI sites, at 
the ends of the homology regions, were not transferred into the fi  nal ARS/
Igh BAC, as homologous recombination must take place inside them. 
  The Not1 insert of this BAC (designated ARS/Igh11) was prepared as 
described at http://www.med.umich.edu/tamc/BACcol.html, and injected 
into fertilized C57BL/6 x SJL F2 oocytes. Transgenic lines were prepared by 
breeding founders to C57BL/6 mice. All experiments involving mice were 
approved by the University of Michigan Committee on the Use and Care of 
Animals, protocol 08147. Deletion of the 28-kb 3     enhancer region was ac-
complished by breeding females with both the ARS/Igh11 transgene and 
the EIIa Cre transgene (  Lakso et al., 1996  ). Intact and Cre-loxP-deleted lines 
of transgenic mice were characterized structurally by evaluation of twelve 
DNA segments spanning the ARS/Igh11 transgene (Fig. S2). Amplifi  cation 
and analysis of C     genomic sequences (  Dunnick et al., 2005  ) and of HS1,2 
and HS3B genomic sequences (  Dunnick et al., 2004  ) have been previously 
described. The amplifi  cation and analysis of seven other gene segments are 
detailed in   Table S3  . The S    1 region (SstI) and S     region (SstI) were ana-
lyzed by Southern hybridization, using published probes (  Hummel et al., 
1987  ). Allelic exclusion and B cell development was evaluated using com-
mercially available monoclonal antibody reagents (BD) and a FACSCanto 
with autocompensation. 
  Detection of CSR.     Secreted IgG1 (anti-IgG1  a   coating), IgG2a (anti-Flag 
coating), and IgA (anti-IgA coating) were detected in supernatants from 1-ml 
cultures of 100,000 transgenic B cells for 7 d. For analysis of transgenic IgA, 
rat monoclonal AD8 (transgenic idiotype;   Hornbeck and Lewis, 1983  ) was 
used as an intermediate antibody. Developing reagents were anti-IgG1, anti-
IgG2a, or anti–rat IgG conjugated to alkaline phosphatase. For analysis of 
nucleic acids, RNA or DNA was prepared from 3-d cultures of B cells at 
1.5 million per ml (  Dunnick et al., 2004  ). Transgene-specifi  c germline tran-
scripts and post-switch transcripts were detected by RT-PCR and restriction 
enzyme digestion which used polymorphisms between the transgenes and 
endogenous genes (  Dunnick et al., 2004, 2005  ). PCRs were done for 30–35 
cycles with extension for 1 min at 72 and denaturation for 1 min at 95. RT-PCR 
for germline, transgenic VDJCH, Iμ, HPRT transcripts, and for DC-PCR 
products for a recombined     1 gene were as published (  Dunnick et al., 2005  ). 
Germline transcripts for the      gene and DC-PCR products for a recom-
bined     2a gene were amplified and analyzed as outlined in   Table S2  ,   
Fig. 3   and   Fig. 5  . 
  Detection of SHM.     For detection of SHM in genomic sequences, trans-
genic mice were immunized with 0.2 ml SRBC (  Dong et al., 2001  ) to 
which ARS-KLH had been conjugated (  Gronowicz et al., 1976  ). 12 d later 
splenocytes were depleted of red blood cells and germinal center B cells 
(B220+, GL7+, and fas+) were sorted. We then prepared genomic DNA 
from these cells using standard procedures, and amplifi  ed 0.8-kb of sequence 
  Our studies presented herein demonstrate that the 28-kb 
3     enhancer region is necessary for wild-type levels of SHM. We 
fi  nd that deletion of the enhancer region signifi  cantly reduces 
SHM to almost background levels. The actual reduction in 
SHM caused by deletion of the 3     enhancers is likely to be even 
greater than we observe here (  Fig. 6  ). In vivo, recombination 
events between the transgenic VDJ and endogenous locus 
dominate in mice whose transgene lacks the 3     enhancers (Re-
sults). Unfortunately, we cannot determine if the DNA we am-
plifi  ed and sequenced for investigation of SHM is linked to a 
transgenic CH gene or an endogenous CH gene because po-
tential recombination events between the transgenic VDJ and 
endogenous CH are likely to occur outside the region we am-
plify. However, some of the mutations from      mice we report 
(  Fig. 6  ) are likely to derive from transgenic VDJ exon associated 
with endogenous CH genes. Hence, some of the mutations we 
assign to the      transgenes should be associated with the endog-
enous genes, and not counted as mutations in an enhancer-
  deleted transgene. Recombination of the transgenic VDJ with 
the endogenous genes is probably the reason the mutation fre-
quency in line 774     remains high at 0.23% (  Fig. 6  ). 
  Some or all of the reduction in SHM is probably secondary 
to a reduction in transcription rate of the VDJ exon; the re-
duction in SHM (  Fig. 6  ) and transcription (  Fig. 1 D  ) are simi-
lar in magnitude. As we argue above, the true reduction in 
SHM may be greater. Therefore, it is also possible that the 
3     enhancer region has a function in SHM independent of tran-
scriptional enhancement (  Kothapalli et al., 2008  ;   Blagodatski 
et al., 2009  ). Results from line 336     would be consistent with 
this notion. This transgenic line suff  ers a twofold reduction in 
surface IgM expression caused by deletion of the 3     enhancers 
(  Fig. 1 D  ), but suff  ers sixfold reduction in SHM (  Fig. 6  ). 
  Our results cannot rule out additional regulatory elements 
in the heavy chain locus, outside the limits of the ARS/Igh 
transgene that further regulate CSR and/or SHM. However, 
they do establish that the 3     regulatory region is necessary for 
both CSR and SHM in the context of the Ig locus. Finally, 
they reveal an unexpected role of the 3     enhancers in suppress-
ing interchromosomal recombination between endogenous 
and transgenic Ig loci, thus hinting at the possibility that the 3     
enhancers are crucial in suppressing chromosomal transloca-
tions that could arise during CSR. 
  MATERIALS AND METHODS 
  Transgenic constructs and mice.     Two copies of the chicken     -globin 
insulator were inserted at the EcoR1 site 3-kb 5     of the assembled anti-ARS 
VDJ. Using oligonucleotide-mediated modifi  cation, a NotI site was inserted 
inside the BamH1 site of a 2.4-kb EcoRI–BamHI fragment (with two copies 
of the insulator) from pJC13-1 (  Saitoh et al., 2000  ). This fragment was built 
into a targeting vector in pSV1.RecA (  Yang et al., 1997  ) with a 1-kb BamHI 
fragment containing JH1 and JH2 for 5     homology and a 5.2-kb EcoRI frag-
ment containing the anti-ARS VDJH2, JH3, and JH4 (  Durdik et al., 1989  ) 
for 3     homology. The orientation and order of the various fragments was 
confi  rmed by appropriate restriction digests of the fi  nal targeting vector. 
  For insertion of a Flag tag at a position three codons in front of the 
C terminus of C    2a, 5     and 3     homology regions were amplifi  ed with the in-
serted Flag tag codons (  Table S1  ) and were brought together by overlap ex-
tension (  Ho et al., 1989  ). The resulting targeting sequences were transferred 2622 Enhancers for class switch and hypermutation   | Dunnick et al. 
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containing the transgenic VDJ exon and downstream JH intron, using prim-
ers 5    -CCTATGATCAGTGTCCTCTCCACACTCC-3     (within trans-
genic VH) and 5    -GGACTCACCTGCAGAGACAGTGACCAG-3     
(JH4). For detection of SHM in mRNA, transgenic mice were immunized 
with 100 μg ARS-KLH in complete Freund’s adjuvant i.p. 21 d later, RNA 
was prepared from T cell–depleted splenocytes of the immunized mice. 
VDJC     sequences were amplifi  ed using 5    -GGTGAAACAGAGGCCTG-
GTC-3     (amplifying 256 bp of transgenic VDJ, starting in the framework 
region 2) and 5    -GCATGATGGGAAGTTCACTGACTG-3     (amplifying 
544 bp of C    1 sequences), 5    -GCTGGGCCAGGTGCTCGAGGTT-3     
(amplifying 230 bp of C    2a), or 5    -TGCTGGGCATTTGCATGGAG-3     
(amplifying 343 bp of the transgenic C    2a). The amplifi  ed sequences were 
cloned and sequenced. 
  Online supplemental material.    Fig. S1 presents the analysis of B cell subsets 
in transgenic mice. Fig. S2 presents the analysis of transgene content in vari-
ous lines of transgenic mice. Fig. S3 presents the dose–response characteristics 
of ELISAs and controls for total Ig expression. Fig. S4 presents expression of 
the     3,     2b, and      heavy chain genes, as well as some of the dose-response 
characteristics of the RT-PCRs. Fig. S5 presents anti-ARS expression after 
immunization of transgenic mice. Tables S1–S3 describe primers and am-
plifi  cation conditions for various PCRs used in transgene construction or in 
detection of various DNA segments or RNAs. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20091280/DC1. 
  We thank Dr. Michael Berton for discussions and for hosting WD during his 
sabbatical leave, during which these experiments were initiated. We also thank Drs. 
Douglas Engel, David Ferguson, and Thomas Waldschmidt for advice during the 
course of this investigation. We thank Dr. Engel for the use of his laboratory’s CHEF 
gel apparatus and for recombinant DNA constructs, and Drs. F.W. Alt, G. Felsenfeld, 
N. Heintz, J. Manis, and E. Selsing for gifts of constructs, reagents, and mice. We 
acknowledge Galina Gavrilina and Maggie Van Keuren for preparation of transgenic 
mice and the Transgenic Animal Model Core of the University of Michigan’s 
Biomedical Research Core Facilities. 
  This work was supported by the National Institutes of Health grants (AI076057 
to W.A. Dunnick and CA098495 to F.N. Papavasiliou). Transgenic core support was 
provided by The University of Michigan Cancer Center (CA46592). 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   11 June 2009 
Accepted:   30 September 2009 
  REFERENCES 
      Blagodatski  ,   A.  ,   V.     Batrak  ,   S.     Schmidl  ,   U.     Schoetz  ,   R.B.     Caldwell  ,   H.   
  Arakawa  , and   J.-M.     Buerstedde  .   2009  .   A cis-acting diversifi  cation ac-
tivator both necessary and suffi   cient for AID-mediated hypermutation.   
    PLoS Genet.       5  :  e1000332  .   doi:10.1371/journal.pgen.1000332     
      Bottaro  ,   A.  ,   F.     Young  ,   J.     Chen  ,   M.     Serwe  ,   F.     Sablitzky  , and   F.W.     Alt  .   1998  . 
  Deletion of the IgH intronic enhancer and associated matrix-attachment 
regions decreases, but does not abolish, class switching at the mu locus.   
    Int. Immunol.       10  :  799  –  806  .   doi:10.1093/intimm/10.6.799     
      Chu  ,   C.C.  ,   W.E.     Paul  , and   E.E.     Max  .   1992  .   Quantitation of immunoglobulin 
mu-gamma 1 heavy chain switch region recombination by a digestion-
circularization polymerase chain reaction method.       Proc. Natl. Acad. Sci. 
USA      .     89  :  6978  –  6982  .   doi:10.1073/pnas.89.15.6978     
      Cogne  ,   M.  , and   B.K.     Birshtein  .   2004  . Regulation of class switch recom-
bination.   In   Molecular Biology of B Cells. T. Honjo, F.W. Alt, M. 
Neuberger, editors. Academic Press, San Diego, CA. 289–305.   
      Cogné  ,   M.  ,   R.     Lansford  ,   A.     Bottaro  ,   J.     Zhang  ,   J.     Gorman  ,   F.     Young  ,   H.-L.   
  Cheng  , and   F.W.     Alt  .   1994  .   A class switch control region at the 3     
end of the immunoglobulin heavy chain locus.       Cell      .     77  :  737  –  747  . 
  doi:10.1016/0092-8674(94)90057-4     
      Collins  ,   J.T.  , and   W.A.     Dunnick  .   1999  .   Cutting edge: IFN-     regulated germ-
line transcripts are expressed from     2a transgenes independently of the 
heavy chain 3     enhancers.       J. Immunol.       163  :  5758  –  5762  .   
      Delpy  ,   L.  ,   M.     Le Bert  ,   M.     Cogné  , and   A.A.     Khamlichi  .   2003  .   Germ-line 
transcription occurs on both the functional and the non-functional al-JEM VOL. 206, November 23, 2009 
Article
2623
      Manis  ,   J.P.  ,   N.     van der Stoep  ,   M.     Tian  ,   R.     Ferrini  ,   L.     Davidson  ,   A.   
  Bottaro  , and   F.W.     Alt  .   1998  .   Class switching in B cells lacking 3     
immunoglobulin heavy chain enhancers.       J. Exp. Med.       188  :  1421  –  1431  . 
  doi:10.1084/jem.188.8.1421     
      Manis  ,   J.P.  ,   M.     Tian  , and   F.W.     Alt  .   2003  .   Mechanism and control of 
class-switch recombination.       Trends Immunol.       23  :  31  –  39  .   doi:10.1016/
S1471-4906(01)02111-1     
      Morvan  ,   C.L.  ,   E.     Pinaud  ,   C.     Decourt  ,   A.     Cuvillier  , and   M.     Cogné  .   2003  . 
  The immunoglobulin heavy-chain locus hs3b and hs4 3     enhancers 
are dispensable for VDJ assembly and somatic hypermutation.       Blood      .   
  102  :  1421  –  1427  .   doi:10.1182/blood-2002-12-3827     
      Muramatsu  ,   M.  ,   K.     Kinoshita  ,   S.     Fagarasan  ,   S.     Yamada  ,   Y.     Shinkai  , and 
  T.     Honjo  .   2000  .   Class switch recombination and hypermutation 
require activation-induced cytidine deaminase (AID), a potential 
RNA editing enzyme.       Cell      .     102  :  553  –  563  .   doi:10.1016/S0092-
8674(00)00078-7     
      Pinaud  ,   E.  ,   A.A.     Khamlichi  ,   C.     Le Morvan  ,   M.     Drouet  ,   V.     Nalesso  ,   M.   
  Le Bert  , and   M.     Cogné  .   2001  .   Localization of the 3     IgH locus ele-
ments that eff  ect long-distance regulation of class switch recombination.   
    Immunity      .     15  :  187  –  199  .   doi:10.1016/S1074-7613(01)00181-9     
      Revy  ,   P.  ,   T.     Muto  ,   Y.     Levy  ,   F.     Geissmann  ,   A.     Plebani  ,   O.     Sanal  ,   N.   
  Catalan  ,   M.     Forveille  ,   R.     Dufourcq-Labelouse  ,   A.     Gennery  ,   et al  .   2000  . 
  Activation-induced cytidine deaminase (AID) defi  ciency causes the au-
tosomal recessive form of the Hyper-IgM syndrome (HIGM2).       Cell      .   
  102  :  565  –  575  .   doi:10.1016/S0092-8674(00)00079-9     
      Reynaud  ,   S.  ,   L.     Delpy  ,   L.     Fleury  ,   H.-L.     Dougier  ,   C.     Sirac  , and   M.     Cogné  . 
  2005  .   Interallelic class switch recombination contributes signifi  cantly to 
class switching in mouse B cells.       J. Immunol.       174  :  6176  –  6183  .   
      Saitoh  ,  N.  ,  A.C.    Bell  ,  F.    Recillas-Targa  ,  A.G.    West  ,  M.    Simpson  ,  M.    Pikaart  , 
and   G.     Felsenfeld  .   2000  .   Structural and functional conservation at the 
boundaries of the chicken     -globin domain.       EMBO J.       19  :  2315  –  2322  . 
  doi:10.1093/emboj/19.10.2315     
      Sakai  ,   E.  ,   A.     Bottaro  , and   F.W.     Alt  .   1999  .   The Ig heavy chain intronic en-
hancer core region is necessary and suffi   cient to promote effi   cient class 
switch recombination.     Int. Immunol.      11  :  1709  –  1713  .  doi:10.1093/intimm/
11.10.1709     
      Seidl  ,   K.J.  ,   J.P.     Manis  ,   A.     Bottaro  ,   J.     Zhang  ,   L.     Davidson  ,   A.     Kisselgof  ,   H.   
  Oettgen  , and   F.W.     Alt  .   1999  .   Position-dependent inhibition of class-
switch recombination by PGK-neor cassettes inserted into the immuno-
globulin heavy chain constant region locus.       Proc. Natl. Acad. Sci. USA      .   
  96  :  3000  –  3005  .   doi:10.1073/pnas.96.6.3000     
      Shi  ,   X.  , and   L.A.     Eckhardt  .   2001  .   Deletional analyses reveal an essential role for 
the hs3b/hs4 IgH 3     enhancer pair in an Ig-secreting but not an earlier-stage 
B cell line.       Int. Immunol.       13  :  1003  –  1012  .   doi:10.1093/intimm/13.8.1003     
      Stavnezer  ,   J.     2000  .   Molecular processes that regulate class switching.       Curr. 
Top. Microbiol. Immunol.       245  :  127  –  168  .   
      Stavnezer-Nordgren  ,   J.  , and   S.     Sirlin  .   1986  .   Specifi  city of immunoglobulin 
heavy chain switch correlates with activity of germline heavy chain 
genes prior to switching.       EMBO J.       5  :  95  –  102  .   
      Storb  ,   U.  , and   J.     Stavnezer  .   2002  .   Immunoglobulin genes: generating di-
versity with AID and UNG.       Curr. Biol.       12  :  R725  –  R727  .   doi:10.1016/
S0960-9822(02)01247-2     
      Terauchi  ,  A.  ,  K.    Hayashi  ,  D.    Kitamura  ,  Y.    Kozono  ,  N.    Motoyama  , and  T.    Azuma  . 
  2001  .   A pivotal role for DNase I-sensitive regions 3b and/or 4 in the induc-
tion of somatic hypermutation of IgH genes.       J. Immunol.       167  :  811  –  820  .   
      Unniraman  ,   S.  , and   D.G.     Schatz  .   2007  .   Strand-biased spreading of mutations 
during somatic hypermutation.       Science      .     317  :  1227  –  1230  .   doi:10.1126/
science.1145065     
      Vincent-Fabert  ,   C.  ,   V.     Truffi   net  ,   R.     Fiancette  ,   N.     Cogné  ,   M.     Cogné  , 
and   Y.     Denizot  .   2009  .   Ig synthesis and class switching do not require 
the presence of the hs4 enhancer in the 3     IgH regulatory region.   
    J. Immunol.       182  :  6926  –  6932  .   doi:10.4049/jimmunol.0900214     
      Wuerff  el  ,   R.  ,   L.     Wang  ,   F.     Grigera  ,   J.     Manis  ,   E.     Selsing  ,   T.     Perlot  ,   F.W.     Alt  , 
  M.     Cogne  ,   E.     Pinaud  , and   A.L.     Kenter  .   2007  .   S-S synapsis during class 
switch recombination is promoted by distantly located transcriptional 
elements and activation-induced deaminase.       Immunity      .     27  :  711  –  722  . 
  doi:10.1016/j.immuni.2007.09.007     
      Xu  ,   M.Z.  , and   J.     Stavnezer  .   1992  .   Regulation of transcription of immuno-
globulin germ-line      1 RNA: analysis of the promoter/enhancer.   
    EMBO J.       11  :  145  –  155  .   
      Yancopoulos  ,   G.D.  ,   R.A.     DePinho  ,   K.A.     Zimmerman  ,   S.G.     Lutzker  ,   N.   
  Rosenberg  , and   F.W.     Alt  .   1986  .   Secondary genomic rearrangement 
events in pre-B cells: VHDJH replacement by a LINE-1 sequence and 
directed class switching.       EMBO J.       5  :  3259  –  3266  .   
      Yang  ,   X.W.  ,   P.     Model  , and   N.     Heintz  .   1997  .   Homologous recombina-
tion based modifi  cation in   Escherichia coli   and germline transmission in 
transgenic mice of a bacterial artifi  cial chromosome.       Nat. Biotechnol.     
  15  :  859  –  865  .   doi:10.1038/nbt0997-859                     